Brightpoint (CELL) Reports Q4 EPS In-line with Estimates; Initiates Cost Cutting Plan
Tweet Send to a Friend
Brightpoint, Inc. (Nasdaq: CELL) reports Q4 adjusted EPS of $0.09, in-line with the analyst estimate of $0.09. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
